Correlation Between Zentalis Pharmaceuticals and Mersana Therapeutics
Can any of the company-specific risk be diversified away by investing in both Zentalis Pharmaceuticals and Mersana Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zentalis Pharmaceuticals and Mersana Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zentalis Pharmaceuticals Llc and Mersana Therapeutics, you can compare the effects of market volatilities on Zentalis Pharmaceuticals and Mersana Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zentalis Pharmaceuticals with a short position of Mersana Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zentalis Pharmaceuticals and Mersana Therapeutics.
Diversification Opportunities for Zentalis Pharmaceuticals and Mersana Therapeutics
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Zentalis and Mersana is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Zentalis Pharmaceuticals Llc and Mersana Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mersana Therapeutics and Zentalis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zentalis Pharmaceuticals Llc are associated (or correlated) with Mersana Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mersana Therapeutics has no effect on the direction of Zentalis Pharmaceuticals i.e., Zentalis Pharmaceuticals and Mersana Therapeutics go up and down completely randomly.
Pair Corralation between Zentalis Pharmaceuticals and Mersana Therapeutics
Given the investment horizon of 90 days Zentalis Pharmaceuticals Llc is expected to under-perform the Mersana Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Zentalis Pharmaceuticals Llc is 1.37 times less risky than Mersana Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The Mersana Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 675.00 in Mersana Therapeutics on September 2, 2024 and sell it today you would lose (447.00) from holding Mersana Therapeutics or give up 66.22% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Zentalis Pharmaceuticals Llc vs. Mersana Therapeutics
Performance |
| Timeline |
| Zentalis Pharmaceuticals |
| Mersana Therapeutics |
Zentalis Pharmaceuticals and Mersana Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zentalis Pharmaceuticals and Mersana Therapeutics
The main advantage of trading using opposite Zentalis Pharmaceuticals and Mersana Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zentalis Pharmaceuticals position performs unexpectedly, Mersana Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mersana Therapeutics will offset losses from the drop in Mersana Therapeutics' long position.| Zentalis Pharmaceuticals vs. Tff Pharmaceuticals | Zentalis Pharmaceuticals vs. Eliem Therapeutics | Zentalis Pharmaceuticals vs. Inhibrx | Zentalis Pharmaceuticals vs. Enliven Therapeutics |
| Mersana Therapeutics vs. Terns Pharmaceuticals | Mersana Therapeutics vs. Amylyx Pharmaceuticals | Mersana Therapeutics vs. Acumen Pharmaceuticals | Mersana Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |